Cyprotex - News
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

Cyprotex Highlights - January 2017


This month, staff at our UK site finally stepped out of our Macclesfield facility for the last time. Relocation into our new state of the art office and laboratory space at Alderley Park was a well-planned operation which, thanks to our dedicated staff, progressed remarkably smoothly with the laboratory operational just a few days after the move. The extensive space we now occupy allows us to continue to invest in innovation and accommodate our growing CRO business.

Amidst this change, Cyprotex's new identity as part of the Evotec Group has inspired an update to our logo. The new imagery intends to communicate the same level of service and reliability for which Cyprotex is known, while clearly demonstrating our new place in the Evotec family.

Our new look will be on display at the SLAS2017 Conference in Washington, D.C., from February 4-8 at booth #1750. This will be Cyprotex's first public appearance as an Evotec company, and we invite you to come by the booth with any questions you might have about the acquisition and our ongoing research. To schedule a meeting, please email us at

Cyprotex's UK facility moves to Alderley Park

We’ve moved! Our UK facility has relocated to new state of the art office and laboratory space at Alderley Park.

Read the press release

Cyprotex move to Alderley Park
Presenting the new look of Cyprotex, an Evotec company

Now that Cyprotex is part of Evotec, it's important that we align our brand. It hasn't changed much, because the way you work with us isn't changing, but it shows that we can now offer the power and depth of Evotec's drug discovery platforms.

Learn more about the acquisition

Cyprotex, an Evotec company
Visit Booth #1750 at SLAS2017

Evotec and Cyprotex will be at SLAS2017 in Washington, D.C.February 4-8. Visit booth #1750 or get in touch to set up an appointment with our scientific experts.

Schedule a meeting

Cyprotex at SLAS 2017
2016 by the numbers

Last year didn't keep the momentum of 2015 in terms of new drug approvals. We take a closer look at the 22 drugs that were approved by the US FDA in 2016 on our blog.

Read the article

2016 FDA Drug Approvals
Contact us

News categories


Contact us to discuss your ADME Tox issues or request a quote

North America (East Coast): 888-297-7683
Europe: +44 1625 505100


or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.